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Abstract
Background: In Asia, stroke incidence varies dramatically from country to country. Little is
known about stroke incidence in Asians/Pacific Islanders in the US, where regional heterogeneity
in Asian/Pacific Islander sub-populations is great. We sought to characterize both the national and
regional incidences of first and recurrent hospitalized acute ischemic stroke, subarachnoid
hemorrhage, and intracerebral hemorrhage in Asians/Pacific Islanders compared to non-Hispanic
whites.
Methods: We used the National Inpatient Sample of the 1997 Healthcare Cost and Utilization
Project. It is a 20% stratified sample of hospitalizations to nonfederal hospitals in the US. National
and regional projections were made using sampling weights specific for patients and hospitals. We
identified stroke subtypes using previously validated ICD-9 codes. Age-adjusted incidence rates
were calculated using the direct method with the US population in 2000 as the standard.
Results: There were 169,386 stroke hospitalizations in the database. Nationally, compared to
whites, Asians/Pacific Islanders were more likely to have subarachnoid hemorrhage (incidence rate
ratio {RR} female: 1.53, 95% CI 1.41–1.65; male RR: 1.13, 95% CI 1.00–1.27) and intracerebral
hemorrhage (female RR 1.29, 95% CI 1.22–1.36; male RR: 1.58, 95% CI 1.50–1.67). However, when
examined by geographic regions, Asians/Pacific Islanders had higher incidence rates of subarachnoid
hemorrhage and intracerebral hemorrhage predominantly in the West, and lower rates of stroke
elsewhere.
Conclusion: Stroke incidence varies 3-fold among Asians/Pacific Islanders residing in different US
regions. Geographic variation is less dramatic in whites. Whether genetic or cultural differences
are responsible for dramatic heterogeneity among Asian/Pacific Islander populations is unclear and
deserves further study.
Background
Stroke is a disease of major importance in Asia. Reported
incidence rates vary dramatically but are generally higher
than those of the US [1-3]. For example, reported inci-
dence rates for overall stroke are 39% greater in Japan [4],
23% greater in Taiwan [5], and 81% greater in Northern
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China[6] compared to the US. It is the second leading
cause of death in China, Korea and Taiwan; third in Japan
and Singapore; sixth in the Philippines; and tenth in Thai-
land [3,7-9].
The incidence of stroke among Asians/Pacific Islanders
(APIs) in the US is largely unstudied. The only major epi-
demiologic study on stroke in a sub-population of APIs
was the Honolulu Heart Program [10]. A recent compari-
son of the 20-year incidence of hospitalized stroke
between Japanese-American men in the Honolulu Heart
Program and white men in the Framingham Study found
a 40% excess of thromboembolic stroke in whites [11].
The incidence of hemorrhagic stroke was similar in the
two cohorts. Another study reported a higher mortality
rate from hemorrhagic stroke in APIs compared to whites
in the US, and that deaths tended to occur at younger ages
for some stroke types among APIs [12]. Some small stud-
ies have reported differences in the distribution of stroke
subtypes between APIs and whites in the US [13,14]. APIs
have constituted only a small proportion of prior popula-
tion-based cohorts in the US.
Although race-ethnic disparities within the US has been a
recent interest [15], the vast majority of studies have
focused on African Americans and Hispanics [16,17], and
few studies have described stroke in APIs in the US. API
constitutes approximately 4% of the total US population
and represents the fastest growing racial-ethnic group in
the country. The Bureau of Census estimates that the
number of Asians aged 25 years or older will increase 5-
fold from 1995 to 2050 and that API will reach 10% of the
US population by the year 2050 [18]. In 1998, the Depart-
ment of Health and Human Services launched the Initia-
tive to Eliminate Racial and Ethnic Disparities in Health
with stroke identified as one of the six targeted conditions,
and Healthy People 2010 prevention agenda[19] has the
same objective.
Examining race-ethnic distributions of stroke incidence
and mortality is required to define the burden of disease
and to help guide the development of directed prevention
programs, and may also be useful in identifying new
genetic or environmental risk factors. We sought to char-
acterize the incidence of hospitalized acute ischemic
stroke, subarachnoid hemorrhage (SAH), and intracere-
bral hemorrhage (ICH) in APIs compared to non-His-
panic whites, using data representative of US
hospitalizations in 1997. To assess whether stroke rates
might differ in API sub-populations in the US, we also
characterized regional variation.
Methods
We used the Nationwide Inpatient Sample of the 1997
Healthcare Cost Utilization Project (HCUP), release 6,
produced by the Agency for Healthcare Research and
Quality [20]. The Nationwide Inpatient Sample (NIS) is a
sample of US community hospitals, including nonfederal,
short-term, general and specialty hospitals. It excludes all
long-term hospitals, psychiatric hospitals, and alcohol-
ism/chemical dependency treatment facilities. The NIS is
based on a 20% stratified probability sample of hospitals
with sampling probabilities proportional to the total
number of US community hospitals in each stratum. The
five stratification variables are geographic region (North-
east, Midwest, South, and West), ownership (government
nonfederal, private not-for-profit, private investor-
owned), location (urban vs. rural), teaching status (teach-
ing vs. non-teaching), and size based on number of beds
(small, medium and large). The database includes infor-
mation typically available from discharge abstracts for
7,148,420 inpatient stays in 1,012 hospitals across 22
geographically dispersed states (AZ, CA, CO, CT, FL, GA,
HI, IL, IA, KS, MD, MA, MO, NJ, NY, OR, PA, SC, TN, UT,
WA, WI). Our study was approved by the Committee on
Human Research at the University of California San Fran-
cisco.
Incidence of hospitalized strokes
HCUP does not distinguish between first and recurrent
stroke admissions; therefore, we report the incidence of
first and recurrent stroke leading to hospitalization. We
identified all patients with a primary diagnosis of stroke
(International Classification of Diseases, Ninth Revision,
[ICD-9] codes 430–434, 436). Stroke subtypes were iden-
tified from previously identified codes [21-23]: acute
ischemic stroke (ICD-9 433.01, 433.11, 433.21, 433.31,
433.81, 433.91, 434.01, 434.11, 434.91, 436), SAH (ICD-
9 430), and ICH (ICD-9 431). For standardization of
stroke incidence, age groups were defined as 0–19 years,
20–29, 30–39, 40–49, 50–59, 60–64, 65–74, 75–84, and
85+. Gender was classified as male and female. Race-eth-
nicity was coded as non-Hispanic white, Black, Hispanic,
API, Native American, and other, based on self-report.
Unadjusted incidence rates were calculated using the
number of cases in the database, the appropriate dis-
charge sampling weights specific for each age group,
stroke type, and race-ethnicity, and with the 1997 non-
Hispanic API or white populations based on Census
Bureau data [24] as the denominators. Age-adjusted and
gender-specific incidence rates were calculated by the
direct method using the entire US population in 2000 as
the standard [25]. The number of exposed individuals for
each age category was calculated by dividing the 1997 US
population in each age category by the discharge sampling
weight for the corresponding age category. Subsequently,
an event rate for each age category was calculated by divid-
ing the number of cases identified in the database by the
number of exposed individuals. Age adjusted rate equalsBMC Neurology 2005, 5:21 http://www.biomedcentral.com/1471-2377/5/21
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to the sum of age-specific rates multiplied by the age-spe-
cific US population proportions. Standard errors for all
age categories were computed, as well as an overall stand-
ard error for the age-adjusted incidence rate. A 95% confi-
dence interval (CI) was equal to the adjusted rate ± 1.96
times the standard error.
Estimates were obtained for national as well as regional
incidences. The four geographical regions were Northeast,
Midwest, South, and West as defined by the US Census
Bureau in 2000 [26]. Point estimates and 95% CI for inci-
dence rate ratios were calculated using non-Hispanic
white as the reference group. Variances for adjusted inci-
dence rates were calculated and regional heterogeneity
was tested using ANOVA. Pair wise t-test with Bonferroni
correction for multiple comparisons was used to deter-
mine statistical differences between pairs of regional inci-
dence rates among APIs and non-Hispanic whites.
Case fatality
Case fatality, or in-hospital death due to all causes, was
calculated for each stroke subtype in non-Hispanic whites,
and APIs. The Wilcoxon rank-sum test was used to evalu-
ate race-ethnic differences in age, and the chi-squared test
was used to test for differences in stroke subtype. Robust
logistic regression [27] was used to calculate the inde-
pendent association between API race and stroke case
fatality. The robust method broadens CI to account for
clustering of covariates and outcomes by hospital. In mul-
tivariable analyses, we adjusted for patient characteristics
such as age, sex, co-morbidity score, length of stay and
median income for patient's zip code. Co-morbidity
Table 1: Characteristics of all hospitalized stroke patients by race-ethnicity.
Asian/Pacific Islanders 
Mean ± SD or no.(%) (n = 2,159)
non-Hispanic Whites 
Mean ± SD or no. (%) (n = 109,632)
Age, years 68.5 ± 14.3 73.3 ± 12.3
Female 47.3 52.1
Region
Northeast 224 (10.4) 26,471 (24.2)
Midwest 52 (2.4) 21,022 (19.2)
South 186 (8.6) 43,080 (39.3)
West 1697 (78.6) 19,059 (17.4)
Urban hospital 2019 (93.5) 93,538 (85.5)
Teaching hospital 821 (38.0) 31,039 (28.4)
Type of hospital
Government, non-fed 432 (20.0) 12,829 (11.7)
Private, not-for-profit 1423 (65.9) 38,748 (72.0)
Private, for-profit 304 (14.1) 17,794 (16.3)
Median income for patient's zip code
$0 – $25,000 254 (12.3) 31,077 (30.3)
$25,001 – $35,000 649 (31.5) 38,748 (37.7)
$35,001 + 1155 (56.1) 32,876 (32.0)
Admit from Emergency Dept 1450 (67.4) 58,970 (56.2)
Length of stay, days 8.2 ± 30.4 5.8 ± 19.4
Expected payer
Medicare 1017 (47.1) 81,956 (74.8)
Medicaid 451 (20.9) 2740 (2.5)
Private 542 (25.1) 21,435 (19.6)
Other 149 (6.9) 3402 (3.1)
Total charges $24,026 ± $34,928 $14,275 ± $21,039
Discharge status
Routine 789 (36.6) 52,698 (48.1)
Home health care 202 (9.4) 8443 (7.7)
Other facility/AMA* 1130 (43) 39,376 (36.1)
Died 238 (11.0) 8891 (8.1)
Average age at death, years 68.3 ± 14.5 75.5 ± 13.0
* AMA = against medical adviceBMC Neurology 2005, 5:21 http://www.biomedcentral.com/1471-2377/5/21
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scores were developed using a database version of the
Charlson comorbidity index and represent a summary of
major secondary diagnoses weighted by severity [28]. We
also adjusted for hospital characteristics including geo-
graphic region, location (urban vs. rural), teaching status
(teaching vs. non-teaching), ownership (government
non-federal, private for profit, private non-profit), and
size (small, medium, large). To determine whether there
was heterogeneity among API populations within the US,
we tested for interactions between ethnicity and region by
using the likelihood-ratio test [29]. The Stata statistical
package was used for all analyses (version 7.0; Stata Cor-
poration, College Station, TX).
Results
There were 169,386 hospitalizations for stroke in the
1997 NIS database. Of these, 102,268 (60.4%) were for
acute ischemic stroke, 5,172 (3.1%) for SAH and 14,907
(8.8%) for ICH. An additional 47,039 (27.7%) were for
non-specific stroke diagnoses, with carotid stenosis or
occlusion (ICD-9 433.1) being the most frequent. Using
the average discharge weight for each stroke subtype, we
calculated the US projections to be 510,113 cases of acute
ischemic stroke, 24,893 cases of SAH, and 73,208 cases of
ICH. Most patients were admitted through the emergency
department (57.9%). The distribution of race-ethnicity
was 80.9% white, 1.6% API, 11.4% African American,
4.7% Hispanic, 0.2% Native American, and 1.3% other.
The overall average age was 71.7 ± 13.4 years, and 52.7%
were female.
Compared to whites, APIs hospitalized with strokes were
younger (Table 1). On average, APIs lived in areas with
higher median incomes, were less likely to be discharged
to home, had longer hospital stays, and incurred higher
total charges. The baseline characteristics for each race-
ethnic group were also examined by stroke subtype. The
results remained similar to those for all strokes combined
in Table 1a, except that APIs with SAH had shorter length
of stay than whites. The mean ± SD age for whites were
74.9 ± 12 years for those hospitalized with ischemic
stroke, 59.3 ± 16.5 years for SAH, and 72.2 ± 14 years for
ICH. APIs were younger across all three stroke subtypes:
71 ± 12.2 years for ischemic stroke, 57.9 ± 18.7 for SAH,
Table 2: Characteristics of all hospitalized Asian patients with stroke by region.
Asian/Pacific Islanders 









Age, years 64.3 ± 15.97 64.7 ± 15.7 66 ± 14.8 69.2 ± 14
Female 44.2 40.4 43.6 48.4
Urban hospital 222 (99.1) 46 (88.5) 184 (98.9) 1567 (92.3)
Teaching hospital 160 (71.4) 19 (36.5) 35 (18.8) 607 (35.8)
Type of hospital
Government, non-federal 64 (28.6) 8 (15.4) 24 (12.9) 336 (19.8)
Private, not-for-profit 155 (69.2) 44 (84.6) 127 (68.3) 1097 (64.6)
Private, for-profit 5 (2.2) 0 35 (18.8) 264 (15.6)
Median income for patient's zip code
$0 – $25,000 21 (9.6) 27 (52.9) 26 (14.8) 180 (11.2)
$25,001 – $35,000 96 (44.0) 11 (21.6) 36 (20.5) 506 (31.4)
$35,001 + 101 (46.3) 13 (25.5) 114 (64.8) 927 (57.5)
Admit from Emergency Dept 168 (75.3) 34 (72.3) 140 (75.7) 1108 (65.4)
Length of stay, days 16.2 ± 87.5 6.1 ± 7.2 7.8 ± 7.9 8.1 ± 17.3
Expected payer
Medicare 75 (33.5) 14 (26.9) 78 (41.9) 850 (50.1)
Medicaid 50 (22.3) 17 (32.7) 35 (18.8) 349 (20.6)
Private 65 (29.0) 14 (26.9) 49 (26.3) 414 (24.4)
Other 34 (15.2) 7 (13.5) 24 (12.9) 84 (4.9)
Total charges $25,570 ± $31,001 $14,172 ± $27,282 $15,151 ± $17,994 $25,161 ± $36,920
Discharge status
Routine 95 (42.8) 24 (46.2) 90 (48.4) 580 (34.2)
Home health 17 (7.7) 7 (13.5) 15 (8.1) 163 (9.6)
Other facility/AMA 82 (36.9) 17 (32.6) 64 (34.4) 765 (45.1)
Died 28 (12.6) 4 (7.7) 17 (9.1) 189 (11.1)
Average age at death, years 69.3 ± 14.4 59.3 ± 23.4 68.6 ± 12.8 68.4 ± 14.5
* AMA = against medical adviceBMC Neurology 2005, 5:21 http://www.biomedcentral.com/1471-2377/5/21
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and 65 ± 15.3 for ICH. Admissions for ICH made up a
larger percentage of total strokes among APIs (17.4%)
compared to non-Hispanic whites (8.1%), which could
account for some differences in mortality outcomes and
age at presentation since patients with ICH tend to be
younger [30]. In addition, some of the patient characteris-
tics for API varied significantly across the four regions
(Table 2). These include type of hospital, median income
for patient's zip code, length of stay, expected payer, and
discharge status.
We calculated the national age-adjusted and gender-spe-
cific incidence rates for hospitalized acute ischemic stroke,
SAH, and ICH. Compared to non-Hispanic whites, APIs
were more likely to have SAH and ICH, but rates of acute
ischemic stroke were similar (Table 3). There was signifi-
cant regional variation in incidence rates. API females had
higher incidence rate ratios for SAH (1.53, 95% CI 1.41–
1.65) and ICH (1.69, 95% CI 1.60–1.79) in the West, but
lower rates of stroke everywhere else in the country com-
pared to non-Hispanic whites. Similarly, API males had
higher incidence rate ratios for acute ischemic stroke
(1.16, 95% CI 1.12–1.21), SAH (1.34, 95% CI 1.12–
1.60), and ICH (2.02, 95% CI 1.87–2.18) in the West. In
addition, API males also had higher incidence rate ratios
for SAH in the Northeast (1.31, 95% CI 1.05–1.63), and
ICH in the South (1.21, 95% CI 1.06–1.38) compared to
non-Hispanic whites. Regional variation was less dra-
matic for whites. There was great heterogeneity in inci-
dence rates across regions within each stratum of stroke
type (Table 3). In addition, pair-wise t-test calculations
revealed that rates for APIs in the West were significantly
different from those of all other regions (p < 0.008, after
Bonferroni correction).
Case fatality
Among all stroke hospitalizations, in-hospital death
occurred in 14,024 (8.3%). The mean ± SD age for those
who died in-hospital was 73.4 ± 14.3 years for all races.
APIs (68.3 ± 14.5 years) died at a younger age than non-
Hispanic whites (75.5 ± 13 years, p < 0.001). These race-
ethnic differences in age at death remained when each
stroke subtype was examined separately (data not
shown). Case fatality for acute ischemic stroke was 7.3%
in white and 6.4% in API (p < 0.001). Case fatality for
SAH was 27.5% in white, 29.8% in API (p = 0.081). Case
fatality for ICH was 31.9% in white, 26.7% in API (p =
0.002).
Table 3: Age-adjusted incidence rates and rate ratios of hospitalized stroke stratified by gender for Asians/Pacific Islanders and non-
Hispanic whites by stroke subtype and US region.*
Incidence Rate per 100,000 (95% CI) Incidence Rate Ratio (95% CI)
Asians/Pacific Islanders Non-Hispanic Whites
Female Male Female Male Female Male
Ischemic Stroke
National 111 (102–120) 106 (98–114) 151 (149–153) 131 (129–133) 0.74 (0.72–0.76) 0.81 (0.78–0.83)
Northeast 72 (50–94) 63 (46–80) 187 (183–191) 162 (158–166) 0.39 (0.36–0.41) 0.39 (0.36–0.42)
Midwest 36 (14–58) 35 (18–52) 116 (113–119) 98 (95–101) 0.31 (0.27–0.36) 0.36 (0.31–0.41)
South 79 (55–104) 84 (62–106) 171 (168–170) 158 (155–161) 0.46 (0.43–0.49) 0.53 (0.50–0.57)
West 120 (109–131) 118 (108–128) 128 (125–131) 101 (98–104) 0.94 (0.91–0.98) 1.16 (1.12–1.21)
Heterogeneity p < 0.001 p < 0.001 p < 0.001 p < 0.001
SAH
National 12 (9–15) 6 (4–8) 8 (7.6–8.4) 5 (4.7–5.3) 1.53 (1.41–1.65) 1.13 (1.00–1.27)
Northeast 5 (0–10) 8 (3–13) 9 (7–10) 6 (5–7) 0.56 (0.41–0.74) 1.31 (1.05–1.63)
Midwest 1 (0–2) 2 (0–5) 7 (6–8) 4 (3–5) 0.09 (0.02–0.23) 0.63 (0.34–1.07)
South 2 (0–4) 1 (0–2) 8 (7–9) 5 (4–6) 0.28 (0.18–0.42) 0.12 (0.04–0.26)
West 16 (12–20) 6 (4–8) 8 (7–9) 5 (4–6) 1.92 (1.73–2.14) 1.34 (1.12–1.60)
Heterogeneity p < 0.001 p = 0.008 p = 0.079 p < 0.001
ICH
National 25 (21–29) 30 (26–34) 20 (19–21) 19 (18–20) 1.29 (1.22–1.36) 1.58 (1.50–1.67)
Northeast 21 (11–25) 19 (11–27) 25 (24–26) 24 (23–25) 0.86 (0.75–0.98) 0.77 (0.66–0.88)
Midwest 8 (0–18) 12 (2–22) 16 (15–17) 14 (13–15) 0.53 (0.40–0.70) 0.87 (0.68–1.11)
South 20 (10–30) 25 (13–37) 22 (21–23) 21 (20–22) 0.94 (0.82–1.08) 1.21 (1.06–1.38)
West 27 (22–32) 35 (30–40) 19 (18–20) 17 (16–18) 1.42 (1.31–1.54) 2.02 (1.87–2.18)
Heterogeneity p = 0.039 p = 0.001 p < 0.001 p < 0.001
* SAH = subarachnoid hemorrhage, ICH = intracerebral hemorrhage. Incidence rate ratio is for Asians/Pacific Islanders vs. non-Hispanic whites. 
Variances for adjusted rates were calculated and regional heterogeneity was tested using ANOVA.BMC Neurology 2005, 5:21 http://www.biomedcentral.com/1471-2377/5/21
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We assessed the odds of in-hospital death by stroke sub-
types for APIs as compared to whites. In univariate analy-
ses, APIs (OR = 0.78, 95% CI 0.61–0.99, p = 0.05)
admitted with ICH were less likely to die in-hospital.
However, the association was no longer significant after
adjustment for patient and hospital characteristics (age,
sex, co-morbidity score, length of stay, and median
income for patient's zip code, geographic region, location,
teaching status, ownership, and bed size). In addition,
there was no interaction between race-ethnicity and
region in case fatality (p = 0.50).
Discussion
Few studies have examined stroke in APIs in the US and
no population-based study on stroke in API is available.
Thus, the incidence of stroke in API in the US is not
known. Using a 1997 national database to overcome
problems with small sample size, we found that the over-
all US incidence rates for SAH and ICH were higher for
APIs than for non-Hispanic whites. Our age-adjusted and
gender-specific incidence rates for total stroke and for
each stroke subtype for non-Hispanic whites are similar to
those reported elsewhere[31,32]. The age and gender-
adjusted incidence of first-ever strokes among whites in
Rochester was 179 per 100,000[31]. A recent population-
based study of the greater Cincinnati metropolitan area
reported the age and gender-adjusted incidence rates for
non-Hispanic whites to be 212 per 100,000 for first and
recurrent strokes, 137 per 100,000 for first ischemic
stroke, 6 per 100,000 for first SAH, and 18 per 100,000 for
first ICH[32].
We found a significant interaction between race-ethnicity
and geographic region. The stroke incidence rates varied
over 3-fold in APIs among different US regions. Geo-
graphic variation was less dramatic in non-Hispanic
whites. It is not likely that the heterogeneity in rates was
due to small numbers given that the incidence rates were
statistically heterogeneous among the regions for all
stroke types. This dramatic regional variation might reflect
the different distributions of subgroups of APIs (such as
Chinese, Japanese, Filipinos, etc.) in the US, as suggested
by the significant differences in patient characteristics
across regions (Table 2). Striking regional differences in
stroke incidence between northern and southern China
[3], and between countries in Asia[7] have been reported.
These reports and our current findings suggest that com-
bining these distinct subpopulations into one race-ethnic
category may be inappropriate.
Our finding of a higher incidence of ICH in APIs is con-
sistent with prior reports from Asia of high rates of hem-
orrhagic strokes in Asians [3,5,33]. Studies from Asia also
reveal a high prevalence of hypertension in these popula-
tions [33]. It is not known how much uncontrolled hyper-
tension contributes to the differential burden of
hemorrhage in APIs in the US. Other differences in diet
(such as a higher salt intake), prevalence of smoking, or
genetic factors might also contribute to this difference in
ICH incidences.
On average, APIs had longer hospital stays for ischemic
stroke and ICH, had higher total hospital charges, and
were more likely to be discharged to another facility rather
than home. These findings were not explained by differ-
ences in stroke subtypes. One possible explanation of
these findings is that APIs are hospitalized with more
severe strokes, as has been suggested by one prior study
showing higher case fatality rates for APIs with ICH [12].
However, we found no significant difference in all-cause
in-hospital mortality between API and non-Hispanic
white after adjusting for important potential confounders.
Whether cultural differences in preferences for end-of-life
care could mask an impact of greater stroke severity on
case fatality cannot be answered in our study.
There are several limitations to our study. We only
included in our analyses patients who were hospitalized
for stroke. Thus, non-hospitalized strokes, which account
for approximately 10% of all strokes in the US [34], were
not included. Furthermore, incidence-rate calculations
were based on all stroke hospitalizations including recur-
rent cases. The accuracy of our incidence estimates
depends on the accuracy of ICD-9 coding in the database.
Although we used only ICD-9 codes that were previously
identified as more accurate in order to enhance the preci-
sion of our estimates, reliability of coding is still imperfect
[21-23]. In addition, by using only ICD-9 codes in the pri-
mary position, we recognize that we increase specificity
but decrease the sensitivity of case ascertainment [35].
Another limitation is the lack of reliable coding for
comorbidities. Consequently, we were unable to fully
adjust for severity of disease or to evaluate risk factors. We
also did not have data on do-not-resuscitate status of the
patients, which could influence the in-hospital mortality
rate. Furthermore, API was not broken down into distinct
ethnic subgroups in the database. This is a problem
encountered by all similar studies. Despite the limita-
tions, the study reveals several important and interesting
findings that deserve further exploration.
Conclusion
In summary, analyses from a large nationwide database
revealed that APIs appear to have a higher risk than non-
Hispanic whites for ICH and SAH. However, differences
between APIs and whites vary dramatically between
regions, with the highest rates among APIs in the West.
Which sub-populations of APIs are at greater risk, and the
factors that predict this elevated risk remain to be deter-
mined. APIs come from nearly 50 distinct countries andBMC Neurology 2005, 5:21 http://www.biomedcentral.com/1471-2377/5/21
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ethnic groups, each with its own set of cultures and tradi-
tions, and potentially very different genetic and/or envi-
ronmental risk factors for stroke. Our findings suggest the
need for further studies to examine the differences in
stroke incidence and risk factors among the subpopula-
tions of APIs. Furthermore, understanding of the racial-
ethnic differences in stroke should lead to the develop-
ment of more efficient and effective stroke prevention
strategies.
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